This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Arginine aspartate is an ingredient in products indicated to treat exhaustion during stress, endurance sports, or in the elderly.

Generic Name
Arginine aspartate
DrugBank Accession Number
DB15993
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 307.307
Monoisotopic: 307.149183416
Chemical Formula
C10H21N5O6
Synonyms
  • Arginine L-aspartate
  • L-Arginine aspartate
  • L-Arginine-L-aspartate
External IDs
  • 231-656-8

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
LZB1G2I725
CAS number
7675-83-4
InChI Key
SUUWYOYAXFUOLX-ZBRNBAAYSA-N
InChI
InChI=1S/C6H14N4O2.C4H7NO4/c7-4(5(11)12)2-1-3-10-6(8)9;5-2(4(8)9)1-3(6)7/h4H,1-3,7H2,(H,11,12)(H4,8,9,10);2H,1,5H2,(H,6,7)(H,8,9)/t4-;2-/m00/s1
IUPAC Name
(2S)-2-amino-5-carbamimidamidopentanoic acid; (2S)-2-aminobutanedioic acid
SMILES
N[C@@H](CC(O)=O)C(O)=O.N[C@@H](CCCNC(N)=N)C(O)=O

References

General References
  1. BASG: Sangenor (Arginine Aspartate) Oral Solution [Link]
ChemSpider
9675306
RxNav
18254

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4TerminatedSupportive CareMuscular Fatigue1
3CompletedTreatmentPeriodontitis1
2CompletedTreatmentClassic Galactosemia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionOral1 g/5mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility2.28 mg/mLALOGPS
logP-3.5ALOGPS
logP-3.2ChemAxon
logS-1.9ALOGPS
pKa (Strongest Acidic)2.41ChemAxon
pKa (Strongest Basic)12.41ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area125.22 Å2ChemAxon
Rotatable Bond Count8ChemAxon
Refractivity53.92 m3·mol-1ChemAxon
Polarizability17.93 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at December 10, 2020 18:29 / Updated at May 05, 2021 20:32